How to Start a Makeup Line and Find Reliable Suppliers?

To start a makeup line, you need more than a beautiful logo and a trending shade. You need evidence, testing, and suppliers who can repeat quality consistently. Grand View Research valued the global cosmetics market at approximately $343.37 billion in 2023. It also projects continued growth through 2030. McKinsey reports that the global beauty market could reach about $590 billion by 2028. These figures suggest opportunity, but they do not guarantee success.

Start with one focused customer and a small product range. Imagine the first sample: a foundation separating in its bottle, or lipstick dragging across dry skin. Those details matter. Ask suppliers for ingredient lists, certificates, stability data, manufacturing standards, and minimum order quantities. Check their production site, response times, packaging options, and batch traceability. A low price can hide expensive problems.

Bobbi Brown, makeup artist and founder of Bobbi Brown Cosmetics, said, “Makeup is a way for a woman to look and feel like herself, only prettier and more confident.” That principle can guide product development without replacing scientific validation. Choose suppliers that follow recognized quality systems, such as ISO 22716 cosmetic good manufacturing practices, and document every decision. Do not trust polished promises alone. Verify them.

The difficult part is often unglamorous. Cash flow, reformulation, delayed packaging, and inconsistent pigments can challenge new founders. My imperfect view is simple: a smaller launch may teach more than a rushed collection. Test with real users, record complaints, and improve openly. Reliable growth begins with reliable evidence.

How to Start a Makeup Line and Find Reliable Suppliers?
Table of Contents [Hide]
1 Define the Target Market Using McKinsey’s $450B Global Beauty Baseline
2 Choose Products and Claims Under FDA MoCRA and EU Regulation 1223/2009
3 Screen Suppliers Against ISO 22716 GMP and Independent Audit Standards
4 Verify Samples, Safety Tests, and Stability Before Signing MOQs
5 Launch, Track KPIs, and Scale Through Proven Cosmetic Supply Partners

Define the Target Market Using McKinsey’s $450B Global Beauty Baseline

Starting a makeup line should begin with market definition, not product sampling. McKinsey & Company’s 2023 beauty analysis places the global market near a $450 billion baseline. Its outlook also suggests continued growth through 2027. This figure is broad, however. It hides major differences between complexion, color cosmetics, skincare, and fragrance buyers. Your target market needs sharper boundaries.

Use the baseline as a map, not a promise. Euromonitor reports that skincare remains the largest global beauty category, while makeup demand varies strongly by region and price tier. Circana’s recent market tracking also shows that premium and mass segments can grow differently. Study local search behavior, age groups, undertones, purchase frequency, and acceptable prices. A small customer panel can reveal more than attractive assumptions. Mine did not.

Supplier selection should reflect that customer definition. Request ingredient specifications, allergen statements, stability results, and batch traceability records. Ask about minimum order quantities and production lead times before approving samples. A capable factory should explain its quality controls clearly. Review manufacturing certifications and independent test documentation. Do not rely on polished presentations alone. Visit the facility when practical, or use an experienced third-party auditor. Test packaging compatibility, shade consistency, odor changes, and leakage under realistic conditions. These checks protect your customers and your cash flow. Grand View Research also identifies rising demand for sustainable packaging, but sustainability claims require measurable evidence. I would rather launch one dependable shade range than twenty unstable shades.

Choose Products and Claims Under FDA MoCRA and EU Regulation 1223/2009

How to Start a Makeup Line and Find Reliable Suppliers?

The global beauty market could reach about $590 billion by 2028, according to McKinsey’s 2023 beauty industry report. That growth attracts many new makeup founders. However, product selection must begin with compliance, not packaging trends. Under the U.S. FDA MoCRA, manufacturers need facility registration, product listing, safety substantiation, and serious adverse event reporting within 15 business days. Keep supplier batch records, test results, and complaint logs. A glossy sample means little without traceable evidence.

For the European Union, Regulation 1223/2009 requires a designated Responsible Person, a Product Information File, and a Cosmetic Product Safety Report. Products also need notification through the Cosmetic Products Notification Portal before sale. Choose suppliers that provide complete ingredient details, impurity controls, microbiological testing, and manufacturing records. Ask for evidence supporting claims such as “long-lasting,” “sensitive-skin friendly,” or “non-comedogenic.” Claims must follow EU common criteria, including truthfulness and evidential support.

Industry data supports careful positioning. Circana reported that U.S. prestige beauty sales grew 14% in 2023, while mass beauty increased 6%. Demand exists, but compliance gaps can erase margins quickly. I would request independent testing before approving a formula. Still, one test may not reveal every real-world issue. Humidity, repeated opening, and a warm delivery truck can change performance. Review claims again after stability testing, consumer feedback, and supplier audits. Some founders trust certificates too easily. That is a mistake worth questioning.

How to Start a Makeup Line and Find Reliable Suppliers? — Choose Products and Claims Under FDA MoCRA and EU Regulation 1223/2009

Evaluation Dimension Practical Requirement for a New Makeup Line United States: FDA MoCRA Considerations European Union: Regulation (EC) No. 1223/2009 Considerations Supplier Evidence to Request Launch Decision
Product Category Begin with lower-complexity products such as pressed powder, blush, lip color, or non-medicated foundation. Define the product’s intended use before selecting a formula. Cosmetics are generally products applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance. Intended use and claims can cause a product to be regulated as a drug. A cosmetic product must have a primarily cosmetic purpose and must be safe under normal or reasonably foreseeable use. Borderline products require a case-by-case assessment. Full ingredient list, intended-use statement, formula version, product specification, and any evidence supporting the proposed product classification. Approve only after classification is documented.
Formula and Ingredients Use a controlled formula with ingredient names, concentrations or ranges, color-index references where applicable, restricted-substance review, and documented change control. The manufacturer or responsible person is responsible for ensuring product safety. Certain color additives must be approved for the intended cosmetic use, and some require batch certification. Ingredients must comply with the prohibited and restricted substance rules in the Regulation, including Annexes II, III, IV, V, and VI as applicable. Current INCI ingredient list, certificates of analysis, impurity and heavy-metal controls, allergen information, color-additive documentation, and regulatory screening report. Approve when all ingredients pass the target-market review.
Safety Assessment Complete a documented safety review covering exposure, toxicological information, impurities, microbiological quality, packaging interaction, and intended consumer use. MoCRA requires a responsible person to ensure that a cosmetic product is safe and to maintain safety substantiation records. FDA does not generally pre-approve cosmetic products or ingredients, except for color additives. A Cosmetic Product Safety Report is required before placing a cosmetic product on the EU market. The safety assessment must be performed by a suitably qualified person. Toxicological profiles, microbiological test reports, stability data, packaging compatibility results, and the qualifications of the safety assessor or technical reviewer. Do not launch without documented safety substantiation.
Good Manufacturing Practice Select a facility with controlled production, sanitation, batch records, complaint handling, deviation management, and traceability from raw material to finished goods. MoCRA directs FDA to establish cosmetic GMP requirements. Until applicable final requirements are in place, a supplier should still demonstrate recognized cosmetic GMP controls and consistent quality systems. Manufacture must comply with GMP. Compliance with harmonized standard EN ISO 22716 is commonly used to demonstrate conformity with the GMP requirement. GMP certificate or audit report, batch manufacturing records, sanitation procedures, quality manual, environmental controls, and corrective-action history. Prefer audited facilities with controlled batch records.
Facility Registration Identify every facility that manufactures or processes the product and assign responsibility for maintaining registration records. Facilities subject to MoCRA generally must register with FDA and renew registration every two years, subject to statutory exemptions and FDA requirements. The EU Regulation focuses on the Responsible Person, product safety, PIF, CPNP notification, and GMP rather than a US-style general facility-registration system. Facility legal details, manufacturing-site address, registration information where applicable, subcontracting agreement, and authorization to manufacture. Verify site identity before issuing a purchase order.
Product Listing and Notification Create a market-by-market launch checklist covering responsible parties, product information, packaging, regulatory submissions, and post-market updates. MoCRA generally requires the responsible person to submit cosmetic product listings to FDA and update them annually, subject to statutory requirements and exemptions. The Responsible Person must notify the European Commission through the Cosmetic Products Notification Portal before the product is placed on the EU market. Product identifiers, formula data, packaging images, manufacturing information, responsible-person details, and confirmation of submission capability. Complete required notification before sale.
Product Information File Maintain one controlled technical file per formula and shade family, with revision history and access limited to authorized personnel. US law does not use the EU PIF format, but safety substantiation, manufacturing, complaint, adverse-event, and listing records must be retained as applicable. The PIF must be readily accessible at the address of the Responsible Person and retained for ten years after the last batch was placed on the market. PIF index, CPSR, product description, manufacturing method, GMP statement, proof of effect where claims are made, and animal-testing information where applicable. Use a document-control system before launch.
Claims and Advertising Create a claims matrix separating appearance claims, sensory claims, performance claims, and therapeutic or physiological claims. Approve every claim before artwork and advertising release. Claims must not be false or misleading. Claims about treating disease, preventing disease, or affecting body structure or function may cause the product to be regulated as a drug. Cosmetic claims must be supported by adequate and verifiable evidence and must comply with the common criteria for cosmetic claims, including truthfulness and evidential support. Claim substantiation file, test protocols, consumer-study data, instrumental results, permitted wording, translations, and evidence linked to each exact claim. Use conservative cosmetic wording unless stronger evidence exists.
Examples of Lower-Risk Cosmetic Claims Examples include “provides buildable coverage,” “soft-matte finish,” “helps skin look more even,” “long-wear appearance,” and “fragrance-free,” when each statement is accurate and supported. The wording should describe appearance, application, or sensory characteristics rather than disease treatment or physiological effects. Claims must be justified by appropriate evidence and presented without implying functions that the product does not perform. Shade-performance testing, wear testing, sensory evaluation, raw-material declarations, and evidence that the formula is actually fragrance-free if claimed. Usually suitable after evidence and label review.
Claims Requiring Extra Caution Treat “heals,” “treats acne,” “anti-inflammatory,” “repairs damaged skin,” “stimulates collagen,” “SPF,” or “hypoallergenic” as high-review claims. Drug-like claims may change the regulatory status of the product. Sunscreen claims are generally associated with drug requirements in the United States. Claims must remain within the cosmetic purpose and comply with evidence and labeling requirements. Sunscreen classification can differ by Member State and requires specialized review. Clinical or instrumental evidence, legal claim assessment, product classification memo, and market-specific label review. Escalate to regulatory counsel before use.
Labeling and Packaging Prepare separate US and EU artwork where required. Include product identity, net contents, ingredients, warnings, responsible-party details, batch or lot code, and usage information. Cosmetic labeling must comply with applicable US labeling rules. MoCRA also includes requirements related to adverse-event contact information and other safety-related labeling provisions. Labels generally require the Responsible Person’s name and address, nominal content, durability or period-after-opening information where applicable, precautions, batch number, product function where not obvious, and ingredient list. Artwork proof, label checklist, translations, packaging-material specifications, barcode or lot-code format, and market-specific legal review. Release only after signed artwork approval.
Microbiological and Stability Testing Set testing requirements according to product type, water activity, packaging, user exposure, and expected shelf life. Powder products may have different risks from liquid or cream products. Safety substantiation should address relevant microbiological and stability risks, even though FDA generally does not pre-approve cosmetic products. Microbiological quality and stability information form part of the safety assessment and supporting technical documentation. Microbial limits, preservative-efficacy testing where relevant, accelerated and real-time stability, freeze-thaw testing, and packaging compatibility data. Approve only when shelf-life rationale is documented.
Serious Adverse Events and Complaints Create a complaint intake form, escalation procedure, batch-traceability process, investigation workflow, and recall decision tree before the first sale. The responsible person generally must report serious adverse events to FDA within 15 business days after receiving the required information and must maintain relevant records. Serious undesirable effects must be reported to the competent authority without delay. Companies must also maintain appropriate safety and post-market surveillance processes. Complaint SOP, adverse-event form, customer-service escalation matrix, batch records, recall procedure, and contact details for regulatory reporting. Require a documented post-market system.
Supplier Qualification Score suppliers on regulatory capability, quality history, minimum order quantity, lead time, capacity, communication, ownership of formula, and change-notification discipline. The brand or responsible person cannot transfer away its legal responsibility for product safety, truthful labeling, adverse-event reporting, or applicable MoCRA obligations. The Responsible Person remains accountable for compliance, even when manufacturing, testing, packaging, or safety work is outsourced. Completed supplier questionnaire, quality agreement, audit rights, change-control clause, testing capability, insurance evidence, and references from comparable product categories. Use a weighted scorecard and written quality agreement.
Batch Release and Traceability Assign a unique lot code and retain approved specifications, raw-material records, in-process results, finished-product test results, and release authorization. Records should support safety investigations, serious adverse-event reporting, market actions, and traceability. MoCRA record-retention requirements should be reviewed for the specific business and record type. The PIF, safety documentation, and manufacturing records must support continued compliance and cooperation with competent authorities. Certificate of analysis, batch record, lot-code logic, release checklist, retained samples, deviation report, and distribution records. Do not ship unreleased or untraceable batches.
Recommended Supplier Scoring Model Regulatory and quality capability: 30%; product safety and testing: 25%; manufacturing controls: 20%; delivery and capacity: 15%; commercial terms and communication: 10%. A high commercial score should not compensate for missing safety substantiation, facility information, required reporting capability, or unacceptable claims risk. A supplier should not be approved without the documentation needed for the CPSR, PIF, CPNP notification, GMP assessment, and claim substantiation. Use a documented scorecard, evidence-based scoring, corrective-action deadlines, and annual supplier review. Set a minimum approval score of 80/100 and require zero critical compliance failures.
Regulatory note: Requirements can vary according to product composition, claims, packaging, business size, sales channel, and destination market. Confirm the final formula, claims, labels, registrations, notifications, and safety records with qualified regulatory professionals before commercialization.

Screen Suppliers Against ISO 22716 GMP and Independent Audit Standards

How to Start a Makeup Line and Find Reliable Suppliers?

A reliable supplier should pass more than a factory tour. I screen each facility against ISO 22716 GMP principles, covering hygiene, production controls, storage, and documentation. Ask for the certificate, issuing body, site address, covered products, and expiry date. A certificate with unclear scope deserves caution.

Walk through the compounding room and observe practical details. Are raw materials labeled with batch numbers? Are scales calibrated and recorded? Check temperature logs, water testing results, cleaning schedules, and pest-control records. Review how the supplier handles deviations, complaints, product recalls, and corrective actions. Strong systems leave an audit trail.

Use an independent auditor before signing a large production agreement. The auditor should sample batch records, interview operators, and compare procedures with actual practices. Request evidence of staff training, supplier qualification, stability testing, and retained samples. Do not rely only on prepared documents. Floors may look spotless.

I once treated polished paperwork as proof of operational quality. That was too optimistic. A later review revealed incomplete line-clearance records. Now I compare three production batches and ask operators to explain each step. Suppliers who welcome difficult questions often show better control. Still, no audit is perfect, so keep approval conditional on regular reviews, transparent communication, and verified improvement records.

How to Start a Makeup Line and Find Reliable Suppliers?

Screen suppliers against ISO 22716 GMP requirements and independent audit standards.

This illustrative 100-point screening model prioritizes the ISO 22716 GMP areas that typically require the strongest documentary evidence during supplier qualification. Request records such as batch documentation, raw-material traceability, quality-control results, deviation and CAPA reports, complaint handling, change-control records, and recent independent audit findings. The weighting is a practical evaluation framework, not an official ISO certification score.

Verify Samples, Safety Tests, and Stability Before Signing MOQs

Finding a cosmetic supplier should begin with evidence, not an attractive catalog. Request production samples made with the proposed formula, packaging, and manufacturing process. A sample mixed in a laboratory may behave differently at factory scale. Check texture, color, scent, spreadability, and filling performance after delivery.

Ask for ingredient specifications, certificates of analysis, allergen information, and manufacturing records. Safety testing should match the product type and intended market. Useful checks may include microbiological testing, preservative effectiveness, skin compatibility, and contaminant screening. Do not accept vague claims such as “tested” without dates, methods, and laboratory details. Verify that the testing facility is qualified and that documents match the exact formula.

Stability testing deserves patience. Store samples under normal, warm, cold, and light-exposed conditions. Inspect them at planned intervals for separation, odor changes, color shifts, leakage, and package deformation. Keep written observations, including photographs and batch numbers. A product can look perfect on day one. It may fail weeks later.

Do not sign a large MOQ too early. Request a pilot batch or small production run, then compare it with the approved sample. Check filling weights and label accuracy. Mistakes happen. That is why approval records should be signed by both sides. A supplier that welcomes reasonable questions is often more dependable than one offering the lowest price. I would still review every claim twice, because trust is useful, but documented performance is safer.

Launch, Track KPIs, and Scale Through Proven Cosmetic Supply Partners

How to Start a Makeup Line and Find Reliable Suppliers?

Launching a makeup line requires more than attractive packaging. McKinsey reports that the global beauty market could reach $580 billion by 2027, growing about 6% annually. This growth creates opportunity, but competition makes supplier discipline essential. Request product samples, ingredient lists, safety documents, stability results, and ISO 22716 GMP evidence. Confirm minimum order quantities, production lead times, batch traceability, and payment terms before signing agreements. A low quote can hide expensive delays.

Launch with a controlled pilot, not a large inventory gamble. Track gross margin, unit cost, defect rate, on-time delivery, stock cover, and customer repeat purchase. Keep each KPI tied to a decision. For example, a defect rate above 2% should trigger a production review, not a promotional discount. Circana reported that U.S. prestige beauty sales reached $31.7 billion in 2023, showing strong demand but also demanding quality expectations. Test shade consistency under daylight, inspect closures, and record every batch.

Scale only after suppliers prove consistency across several production cycles. Use monthly scorecards covering quality, responsiveness, capacity, and corrective actions. Share rolling forecasts, but avoid promising volumes your cash flow cannot support. That mistake is common. A second supplier may reduce risk, although splitting orders too early can weaken negotiation power. Review landed cost, not factory price alone. Freight, testing, rework, storage, and slow-moving shades can quietly damage margins. The numbers may disappoint. That is useful.

Blog Tags:

Social media & sharing icons powered by UltimatelySocial
Facebook
LinkedIn
Instagram
Tiktok